125 SUMMER STREET, BOSTON, MA
Haemonetics Corporation Repays 0.00% Convertible Senior Notes Due 2026
Haemonetics Corporation Publishes 2024-2025 Corporate Responsibility Report
Reports Third Quarter and Year-to-Date Fiscal 2026 Results; Raises Total Company Fiscal 2026 Guidance
Acquires Vivasure Medical Limited
Reports Second Quarter and First Half Fiscal 2026 Results; Raises Total Company Fiscal 2026 Guidance
Reports First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance
Shareholder votes
Annual Report to Security Holders
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report